25 August 2002
The Medicines Control Council (MCC) threatens to de-register Nevirapine unless further studies and appropriate documentation can show its efficacy in the prevention of mother to child transmission of HIV .Glenda Grey of the perinatal HIV Research Unit at Chris Hani Baragwanath Hospital argues that enough evidence has already been presented, which suggest that Nevirapine with supplement does contain the mother to child transmission.
References

Health Systems Trust Nevirapine, Aids drug could be banned [online] Available at: www.hst.org.za [Accessed on 26 August 2013]|

All Africa South Africa: De-registration of Nevirapine unlikely:TAC [online] Available at: https://allafrica.com [Accessed on 26 August 2013]